M&A Deal Summary

Nexelis Acquires AIT Bioscience

On July 22, 2020, Nexelis acquired life science company AIT Bioscience

Acquisition Highlights
  • This is Nexelis’ 4th transaction in the Life Science sector.
  • This is Nexelis’ 2nd transaction in the United States.
  • This is Nexelis’ 1st transaction in Indiana.

M&A Deal Summary
Date 2020-07-22
Target AIT Bioscience
Sector Life Science
Buyer(s) Nexelis
Deal Type Add-on Acquisition

Target

AIT Bioscience

Indianapolis, Indiana, United States
AIT Bioscience is an integrated bioanalytical laboratory with LC-MS and immunoassay testing capabilities which operates a paperless FDA-inspected facility supported by state-of-the-art electronic systems. AIT Bioscience is based in Indianapolis, Indiana.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Nexelis

Laval, Quebec, Canada
Category Company
Sector Life Science
DESCRIPTION

Nexelis is an immunology-centric CRO specialized in preclinical models and clinical assay development in single and multiplex formats and sample analysis for low-, mid- and large-scale clinical testing. the company's team of scientists and technology platforms have been instrumental in the development, qualification, and validation of assays supporting FDA filings of over 100 new molecular entities, including blockbuster biologics such as vaccines and complex large molecules.

DEAL STATS #
Overall 4 of 5
Sector (Life Science) 4 of 5
Type (Add-on Acquisition) 4 of 4
State (Indiana) 1 of 1
Country (United States) 2 of 2
Year (2020) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-03-04 ImmunXperts SA

Gosselies, Belgium

ImmunXperts SA offers immunology solutions to the broad life sciences community. The company is a specialized service provider focusing on immuno-oncology and immunogenicity. It offers a wide range of in vitro functional screening and custom in vitro assays. ImmunXperts was formed in 2014 and is based in Gosselies, Belgium.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-20 GlaxoSmithKline - The Clinical Laboratory Science

Marburg, Germany

GlaxoSmithKline plc - The Clinical Laboratory Science consisting of approximately 80 scientists and analysts support the development of the future vaccine.

Buy -
Mergr

Product

Company

Legal